Vivus Escapes Shareholder Suit Over Obesity Drug Safety
A California federal judge on Thursday dismissed a putative class action accusing drugmaker Vivus Inc. of lying to investors about the risks of its recently approved obesity treatment Qsymia, ruling the...To view the full article, register now.
Already a subscriber? Click here to view full article